About Site 560: University of Diponegoro/ Dr. Kariadi Hospital
The Dr. Kariadi Central General Hospital or RSUP. Dr. Kariadi, is a hospital affiliated with the Faculty of Medicine Diponegoro University. It is one of the leading hospitals of Indonesia, sited in Semarang, Central Java.
Top Sponsors
Top Collaborators
Trials By Phase
Recruitment Status
Top Conditions
Intervention Types
Top Intervention Names
Trials By Gender
Lead Sponsor
# Trials
Clinical Trials at Site 560: University of Diponegoro/ Dr. Kariadi Hospital
During the past decade, Site 560: University of Diponegoro/ Dr. Kariadi Hospital conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
A Study to Find Out if Selexipag is Effective and Safe in Patients With Chronic Thromboembolic Pulmonary Hypertension When the Disease is Inoperable or Persistent/Recurrent After Surgery and/or Interventional Treatment
Outcome Study Assessing a 75 Milligrams (mg) Dose of Macitentan in Patients With Pulmonary Arterial Hypertension
2020-06-30
2026-09-21
Recruiting
900
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Site 560: University of Diponegoro/ Dr. Kariadi Hospital"
#1 collaborator was "National Institute of Health Research and Development, Ministry of Health Republic of Indonesia" with 3 trials as a collaborator, "PT AIVITA Biomedika Indonesia" with 2 trials as a collaborator, "Aivita Biomedical, Inc." with 1 trials as a collaborator, "Faculty of Medicine University of Diponegoro, Indonesia" with 1 trials as a collaborator and "Indonesia Ministry of Health" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 8 trials.
Clinical Trials Conditions at Site 560: University of Diponegoro/ Dr. Kariadi Hospital
According to Clinical.Site data, the most researched conditions in "Site 560: University of Diponegoro/ Dr. Kariadi Hospital" are
"COVID-19" (2 trials), "HIV" (1 trials), "Infectious Disease" (1 trials), "Lung Tuberculosis" (1 trials) and "MDR TB" (1 trials). Many other conditions were trialed in "Site 560: University of Diponegoro/ Dr. Kariadi Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Site 560: University of Diponegoro/ Dr. Kariadi Hospital
Most popular intervention types in "Site 560: University of Diponegoro/ Dr. Kariadi Hospital" are "Biological" (2 trials) and "Other" (2 trials). Other intervention types were less common.
The name of intervention was led by "AV-COVID-19" (2 trials), "GM-CSF" (1 trials) and "No Intervention" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Site 560: University of Diponegoro/ Dr. Kariadi Hospital
The vast majority of trials in "Site 560: University of Diponegoro/ Dr. Kariadi Hospital" are
5 trials for "All" genders.
Clinical Trials Status at Site 560: University of Diponegoro/ Dr. Kariadi Hospital
Currently, there are NaN active trials in "Site 560: University of Diponegoro/ Dr. Kariadi Hospital".
undefined are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Site 560: University of Diponegoro/ Dr. Kariadi Hospital,
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Site 560: University of Diponegoro/ Dr. Kariadi Hospital, 2 "Phase 1"
clinical trials were conducted, 0 "Phase 2" clinical
trials and 0 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".